/index.php?option=com_iwpfile&file=/dir_04/he2004_2847.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_2846.pdf

NEWS FROM . . . REP. BART STUPAK

Michigan's 1st Congressional District

For Immediate Release

November 19th, 2004

Contact: Chani Wiggins

(202) 225-4735

Statement of Rep. Bart Stupak (D-MI)

11/18 Senate Committee Hearing: FDA Oversight/Regulation Of Prescription Drugs


/index.php?option=com_iwpfile&file=/dir_04/he2004_2844.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_2843.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_2842.pdf

Development Of Form SSA-1020 Form SSA-1020 Form SSA-1021

Guidance To Industry: Changes To An Approved NDA Or ANDA; Specifications -- Use Of Enforcement Discretion For Compendia1 Changes Federal Register Notice

/index.php?option=com_iwpfile&file=/dir_04/he2004_2839.pdf

/index.php?option=com_iwpfile&file=/dir_04/he2004_2838.pdf

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.